Skip to main content
Erschienen in: Surgical Endoscopy 5/2010

01.05.2010

Evaluating outcomes of endoscopic full-thickness plication for gastroesophageal reflux disease (GERD) with impedance monitoring

verfasst von: Daniel von Renteln, Arthur Schmidt, Bettina Riecken, Karel Caca

Erschienen in: Surgical Endoscopy | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Endoscopic full-thickness plication allows transmural suturing at the gastroesophageal junction to recreate the antireflux barrier. Multichannel intraluminal impedance monitoring (MII) can be used to detect nonacid or weakly acidic reflux, acidic swallows, and esophageal clearance time. This study used MII to evaluate the outcome of endoscopic full-thickness plication.

Methods

In this study, 12 subsequent patients requiring maintenance proton pump inhibitor therapy underwent endoscopic full-thickness plication for treatment of gastroesophageal reflux disease. With patients off medication, MII was performed before and 6-months after endoscopic full-thickness plication.

Results

The total median number of reflux episodes was significantly reduced from 105 to 64 (p = 0.016). The median number of acid reflux episodes decreased from 73 to 43 (p = 0.016). Nonacid reflux episodes decreased from 23 to 21 (p = 0.306). The median bolus clearance time was 12 s before treatment and 11 s at 6 months (p = 0.798). The median acid exposure time was reduced from 6.8% to 3.4% (p = 0.008), and the DeMeester scores were reduced from 19 to 12 (p = 0.008).

Conclusion

Endoscopic full-thickness plication significantly reduced total reflux episodes, acid reflux episodes, and total reflux exposure time. The DeMeester scores and total acid exposure time for the distal esophagus were significantly improved. No significant changes in nonacid reflux episodes and median bolus clearance time were encountered.
Literatur
1.
Zurück zum Zitat Dent J, El-Serag HB, Wallander MA, Johansson S (2005) Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 54:710–717CrossRefPubMed Dent J, El-Serag HB, Wallander MA, Johansson S (2005) Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 54:710–717CrossRefPubMed
2.
Zurück zum Zitat Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R (2006) The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101:1900–1920CrossRefPubMed Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R (2006) The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101:1900–1920CrossRefPubMed
3.
Zurück zum Zitat Klinkenberg-Knol EC, Festen HP, Meuwissen SG (1995) Pharmacological management of gastro-oesophageal reflux disease. Drugs 49:695–710CrossRefPubMed Klinkenberg-Knol EC, Festen HP, Meuwissen SG (1995) Pharmacological management of gastro-oesophageal reflux disease. Drugs 49:695–710CrossRefPubMed
4.
Zurück zum Zitat Pace F, Santalucia F, Bianchi Porro G (1991) Natural history of gastro-oesophageal reflux disease without oesophagitis. Gut 32:845–848CrossRefPubMed Pace F, Santalucia F, Bianchi Porro G (1991) Natural history of gastro-oesophageal reflux disease without oesophagitis. Gut 32:845–848CrossRefPubMed
5.
Zurück zum Zitat Mainie I, Tutuian R, Shay S, Vela M, Zhang X, Sifrim D, Castell DO (2006) Acid and nonacid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 55:1398–1402CrossRefPubMed Mainie I, Tutuian R, Shay S, Vela M, Zhang X, Sifrim D, Castell DO (2006) Acid and nonacid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 55:1398–1402CrossRefPubMed
6.
Zurück zum Zitat Sifrim D, Castell D, Dent J, Kahrilas PJ (2004) Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 53:1024–1031CrossRefPubMed Sifrim D, Castell D, Dent J, Kahrilas PJ (2004) Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 53:1024–1031CrossRefPubMed
7.
Zurück zum Zitat Zerbib F, Duriez A, Roman S, Capdepont M, Mion F (2008) Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors. Gut 57:156–160CrossRefPubMed Zerbib F, Duriez A, Roman S, Capdepont M, Mion F (2008) Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors. Gut 57:156–160CrossRefPubMed
8.
Zurück zum Zitat Schilling D, Kiesslich R, Riemann JF, Riemann JF (2005) Endoluminal therapy of GERD with a new endoscopic suturing device. Gastrointest Endosc 62:37–43CrossRefPubMed Schilling D, Kiesslich R, Riemann JF, Riemann JF (2005) Endoluminal therapy of GERD with a new endoscopic suturing device. Gastrointest Endosc 62:37–43CrossRefPubMed
9.
Zurück zum Zitat Pleskow D, Rothstein R, Kozarek R, Haber G, Gostout C, Lembo A (2006) Endoscopic full-thickness plication for the treatment of GERD: long-term multicenter results. Surg Endosc 21:439–444CrossRefPubMed Pleskow D, Rothstein R, Kozarek R, Haber G, Gostout C, Lembo A (2006) Endoscopic full-thickness plication for the treatment of GERD: long-term multicenter results. Surg Endosc 21:439–444CrossRefPubMed
10.
Zurück zum Zitat McClusky DA, Khaitan L, Swafford VA, Smith CD (2007) Radiofrequency energy delivery to the lower esophageal sphincter (Stretta procedure) in patients with recurrent reflux after antireflux surgery: can surgery be avoided? Surg Endosc 21:1207–1211CrossRefPubMed McClusky DA, Khaitan L, Swafford VA, Smith CD (2007) Radiofrequency energy delivery to the lower esophageal sphincter (Stretta procedure) in patients with recurrent reflux after antireflux surgery: can surgery be avoided? Surg Endosc 21:1207–1211CrossRefPubMed
11.
Zurück zum Zitat Triadafilopoulos G, Di Baise JK, Nostrant TT, Stollman NH, Anderson PK, Wolfe MM, Rothstein RI, Wo JM, Corley DA, Patti MG, Antignano LV, Goff JS, Edmundowicz SA, Castell DO, Rabine JC, Kim MS, Utley DS (2002) The Stretta procedure for the treatment of GERD: 6- and 12-month follow-up of the U.S. open label trial. Gastrointest Endosc 55:149–156CrossRefPubMed Triadafilopoulos G, Di Baise JK, Nostrant TT, Stollman NH, Anderson PK, Wolfe MM, Rothstein RI, Wo JM, Corley DA, Patti MG, Antignano LV, Goff JS, Edmundowicz SA, Castell DO, Rabine JC, Kim MS, Utley DS (2002) The Stretta procedure for the treatment of GERD: 6- and 12-month follow-up of the U.S. open label trial. Gastrointest Endosc 55:149–156CrossRefPubMed
12.
Zurück zum Zitat Tam WCE, Schoeman MN, Zhang Q, Dent J, Rigda R, Utley D, Holloway RH (2003) Delivery of radiofrequency energy to the lower oesophageal sphincter and gastric cardia inhibits transient lower oesophageal sphincter relaxations and gastro-oesophageal reflux in patients with reflux disease. Gut 52:479–485CrossRefPubMed Tam WCE, Schoeman MN, Zhang Q, Dent J, Rigda R, Utley D, Holloway RH (2003) Delivery of radiofrequency energy to the lower oesophageal sphincter and gastric cardia inhibits transient lower oesophageal sphincter relaxations and gastro-oesophageal reflux in patients with reflux disease. Gut 52:479–485CrossRefPubMed
13.
Zurück zum Zitat Birk J, Pruitt R, Haber G, Raijman I, Baluyut A, Meiselman M, Sedghi S (2009) The Plicator procedure for the treatment of gastroesophageal reflux disease: a registry study. Surg Endosc 23:423–431CrossRefPubMed Birk J, Pruitt R, Haber G, Raijman I, Baluyut A, Meiselman M, Sedghi S (2009) The Plicator procedure for the treatment of gastroesophageal reflux disease: a registry study. Surg Endosc 23:423–431CrossRefPubMed
14.
Zurück zum Zitat Corley DA, Katz P, Wolfe MM, Stefan A, Patti M, Rothstein R, Edmundowicz S, Kline M, Mason R, Wolfe MM (2003) Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology 125:668–676CrossRefPubMed Corley DA, Katz P, Wolfe MM, Stefan A, Patti M, Rothstein R, Edmundowicz S, Kline M, Mason R, Wolfe MM (2003) Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology 125:668–676CrossRefPubMed
15.
Zurück zum Zitat Pleskow D, Rothstein R, Kozarek R, Haber G, Gostout C, Lembo A (2008) Endoscopic full-thickness plication for the treatment of GERD: five-year long-term multicenter results. Surg Endosc 22:326–332CrossRefPubMed Pleskow D, Rothstein R, Kozarek R, Haber G, Gostout C, Lembo A (2008) Endoscopic full-thickness plication for the treatment of GERD: five-year long-term multicenter results. Surg Endosc 22:326–332CrossRefPubMed
16.
Zurück zum Zitat Deviere J, Costamagna G, Neuhaus H, Voderholzer W, Louis H, Tringali A, Marchese M, Fiedler T, Darb-Esfahani P, Schumacher B (2005) Nonresorbable copolymer implantation for gastroesophageal reflux disease: a randomized sham-controlled multicenter trial. Gastroenterology 128:532–540CrossRefPubMed Deviere J, Costamagna G, Neuhaus H, Voderholzer W, Louis H, Tringali A, Marchese M, Fiedler T, Darb-Esfahani P, Schumacher B (2005) Nonresorbable copolymer implantation for gastroesophageal reflux disease: a randomized sham-controlled multicenter trial. Gastroenterology 128:532–540CrossRefPubMed
17.
Zurück zum Zitat Rothstein R, Filipi C, Caca K, Pruitt R, Mergener K, Torquati A, Haber G, Chen Y, Chang K, Wong D, Deviere J, Pleskow D, Lightdale C, Ades A, Kozarek R, Richards W, Lembo A (2006) Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease: a randomized, sham-controlled trial. Gastroenterology 131:704–712CrossRefPubMed Rothstein R, Filipi C, Caca K, Pruitt R, Mergener K, Torquati A, Haber G, Chen Y, Chang K, Wong D, Deviere J, Pleskow D, Lightdale C, Ades A, Kozarek R, Richards W, Lembo A (2006) Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease: a randomized, sham-controlled trial. Gastroenterology 131:704–712CrossRefPubMed
18.
Zurück zum Zitat Schiefke I, Zabel-Langhennig S, Neumann S, Feisthammel J, Moessner J, Caca K (2005) Long-term failure of endoscopic gastroplication (EndoCinch). Gut 54:752–758CrossRefPubMed Schiefke I, Zabel-Langhennig S, Neumann S, Feisthammel J, Moessner J, Caca K (2005) Long-term failure of endoscopic gastroplication (EndoCinch). Gut 54:752–758CrossRefPubMed
19.
Zurück zum Zitat von Renteln D, Brey U, Riecken B, Caca K (2008) Endoscopic full-thickness plication (Plicator) with two serially placed implants improves esophagitis, reduces PPI use and esophageal acid exposure. Endoscopy 40:173–178CrossRef von Renteln D, Brey U, Riecken B, Caca K (2008) Endoscopic full-thickness plication (Plicator) with two serially placed implants improves esophagitis, reduces PPI use and esophageal acid exposure. Endoscopy 40:173–178CrossRef
20.
Zurück zum Zitat von Renteln D, Schiefke I, Fuchs K, Raczynski S, Philipper M, Breithaupt W, Caca K, Neuhaus H (2008) Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease by application of multiple plicator implants: a multicenter study. Gastrointest Endosc 68:833–844CrossRef von Renteln D, Schiefke I, Fuchs K, Raczynski S, Philipper M, Breithaupt W, Caca K, Neuhaus H (2008) Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease by application of multiple plicator implants: a multicenter study. Gastrointest Endosc 68:833–844CrossRef
21.
Zurück zum Zitat Sgromo B, Irvine LA, Cuschieri A, Shimi SM (2008) Long-term comparative outcome between laparoscopic total Nissen and Toupet fundoplication: symptomatic relief, patient satisfaction, and quality of life. Surg Endosc 22:1048–1053CrossRefPubMed Sgromo B, Irvine LA, Cuschieri A, Shimi SM (2008) Long-term comparative outcome between laparoscopic total Nissen and Toupet fundoplication: symptomatic relief, patient satisfaction, and quality of life. Surg Endosc 22:1048–1053CrossRefPubMed
22.
Zurück zum Zitat Johnson LF, De Meester TR (1974) Twenty-four-hour pH monitoring of the distal esophagus: a quantitative measure of gastroesophageal reflux. Am J Gastroenterol 62:325–332PubMed Johnson LF, De Meester TR (1974) Twenty-four-hour pH monitoring of the distal esophagus: a quantitative measure of gastroesophageal reflux. Am J Gastroenterol 62:325–332PubMed
23.
Zurück zum Zitat Shay S, Richter JE (1998) Importance of additional reflux events during esophageal acid clearing. Dig Dis Sci 43:95–102CrossRefPubMed Shay S, Richter JE (1998) Importance of additional reflux events during esophageal acid clearing. Dig Dis Sci 43:95–102CrossRefPubMed
24.
Zurück zum Zitat Shay S, Tutuian R, Sifrim D, Vela M, Wise J, Balaji N, Zhang X, Adhami T, Murray J, Peters J, Castell D (2004) Twenty-four-hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol 99:1037–1043CrossRefPubMed Shay S, Tutuian R, Sifrim D, Vela M, Wise J, Balaji N, Zhang X, Adhami T, Murray J, Peters J, Castell D (2004) Twenty-four-hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol 99:1037–1043CrossRefPubMed
25.
Zurück zum Zitat Johnsson F, Joelsson B, Isberg PE (1987) Ambulatory 24-hour intraesophageal pH-monitoring in the diagnosis of gastroesophageal reflux disease. Gut 28:1145–1150CrossRefPubMed Johnsson F, Joelsson B, Isberg PE (1987) Ambulatory 24-hour intraesophageal pH-monitoring in the diagnosis of gastroesophageal reflux disease. Gut 28:1145–1150CrossRefPubMed
26.
Zurück zum Zitat Emde C, Garner A, Blum AL (1987) Technical aspects of intraluminal pH-metry in man: current status and recommendations. Gut 28:1177–1188CrossRefPubMed Emde C, Garner A, Blum AL (1987) Technical aspects of intraluminal pH-metry in man: current status and recommendations. Gut 28:1177–1188CrossRefPubMed
27.
Zurück zum Zitat Fletcher J, Wirz A, Henry E, McColl KEL (2004) Studies of acid exposure immediately above the gastro-oesophageal squamocolumnar junction: evidence of short segment reflux. Gut 53:168–173CrossRefPubMed Fletcher J, Wirz A, Henry E, McColl KEL (2004) Studies of acid exposure immediately above the gastro-oesophageal squamocolumnar junction: evidence of short segment reflux. Gut 53:168–173CrossRefPubMed
28.
Zurück zum Zitat Pandolfino JE, Zhang Q, Schreiner MA, Ghosh S, Roth MP, Kahrilas PJ (2005) Acid reflux event detection using the Bravo wireless versus the Slimline catheter pH systems: why are the numbers so different? Gut 54:1687–1692CrossRefPubMed Pandolfino JE, Zhang Q, Schreiner MA, Ghosh S, Roth MP, Kahrilas PJ (2005) Acid reflux event detection using the Bravo wireless versus the Slimline catheter pH systems: why are the numbers so different? Gut 54:1687–1692CrossRefPubMed
29.
Zurück zum Zitat Bredenoord AJ, Weusten BLAM, Smout AJ (2005) Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring. Gut 54:1810–1817CrossRefPubMed Bredenoord AJ, Weusten BLAM, Smout AJ (2005) Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring. Gut 54:1810–1817CrossRefPubMed
30.
Zurück zum Zitat Sifrim D, Silny J, Holloway RH, Janssens J (1999) Patterns of gas and liquid reflux during transient lower oesophageal sphincter relaxation: a study using intraluminal electrical impedance. Gut 44:47–54PubMedCrossRef Sifrim D, Silny J, Holloway RH, Janssens J (1999) Patterns of gas and liquid reflux during transient lower oesophageal sphincter relaxation: a study using intraluminal electrical impedance. Gut 44:47–54PubMedCrossRef
31.
Zurück zum Zitat Tutuian R, Castell DO (2003) Use of multichannel intraluminal impedance to document proximal esophageal and pharyngeal nonacidic reflux episodes. Am J Med 115:119–123CrossRef Tutuian R, Castell DO (2003) Use of multichannel intraluminal impedance to document proximal esophageal and pharyngeal nonacidic reflux episodes. Am J Med 115:119–123CrossRef
32.
Zurück zum Zitat Sifrim D, Dupont L, Blondeau K, Tack J, Janssens J (2005) Weakly acidic reflux in patients with chronic unexplained cough during 24-hour pressure, pH, and impedance monitoring. Gut 54:449–454CrossRefPubMed Sifrim D, Dupont L, Blondeau K, Tack J, Janssens J (2005) Weakly acidic reflux in patients with chronic unexplained cough during 24-hour pressure, pH, and impedance monitoring. Gut 54:449–454CrossRefPubMed
33.
Zurück zum Zitat Tutuian R, Castell DO (2004) Combined multichannel intraluminal impedance and manometry clarifies esophageal function abnormalities: study in 350 patients. Am J Gastroenterol 99:1011–1019CrossRefPubMed Tutuian R, Castell DO (2004) Combined multichannel intraluminal impedance and manometry clarifies esophageal function abnormalities: study in 350 patients. Am J Gastroenterol 99:1011–1019CrossRefPubMed
34.
Zurück zum Zitat Bredenoord AJ, Weusten BL, Timmer R, Smout AJ (2006) Characteristics of gastroesophageal reflux in symptomatic patients with and without excessive esophageal acid exposure. Am J Gastroenterol 101:2470–2475PubMed Bredenoord AJ, Weusten BL, Timmer R, Smout AJ (2006) Characteristics of gastroesophageal reflux in symptomatic patients with and without excessive esophageal acid exposure. Am J Gastroenterol 101:2470–2475PubMed
35.
Zurück zum Zitat Bredenoord AJ, Weusten BLAM, Sifrim D, Timmer R, Smout AJ (2004) Aerophagia, gastric, and supragastric belching: a study using intraluminal electrical impedance monitoring. Gut 53:1561–1565CrossRefPubMed Bredenoord AJ, Weusten BLAM, Sifrim D, Timmer R, Smout AJ (2004) Aerophagia, gastric, and supragastric belching: a study using intraluminal electrical impedance monitoring. Gut 53:1561–1565CrossRefPubMed
36.
Zurück zum Zitat Balaji NS, Blom D, De Meester TR, Peters JH (2003) Redefining gastroesophageal reflux (GER). Surg Endosc 17:1380–1385CrossRefPubMed Balaji NS, Blom D, De Meester TR, Peters JH (2003) Redefining gastroesophageal reflux (GER). Surg Endosc 17:1380–1385CrossRefPubMed
37.
Zurück zum Zitat Gruebel C, Linke G, Tutuian R, Hebbard G, Zerz A, Meyenberger C, Borovicka J (2008) Prospective study examining the impact of multichannel intraluminal impedance on antireflux surgery. Surg Endosc 22:1241–1247CrossRefPubMed Gruebel C, Linke G, Tutuian R, Hebbard G, Zerz A, Meyenberger C, Borovicka J (2008) Prospective study examining the impact of multichannel intraluminal impedance on antireflux surgery. Surg Endosc 22:1241–1247CrossRefPubMed
38.
Zurück zum Zitat del Genio G, Tolone S, del Genio F, Rossetti G, Brusciano L, Pizza F, Fei L, del Genio A (2008) Total fundoplication controls acid and nonacid reflux: evaluation by pre- and postoperative 24-h pH-multichannel intraluminal impedance. Surg Endosc 22:2518–2523CrossRefPubMed del Genio G, Tolone S, del Genio F, Rossetti G, Brusciano L, Pizza F, Fei L, del Genio A (2008) Total fundoplication controls acid and nonacid reflux: evaluation by pre- and postoperative 24-h pH-multichannel intraluminal impedance. Surg Endosc 22:2518–2523CrossRefPubMed
39.
Zurück zum Zitat Torquati A, Richards WO (2007) Endoluminal GERD treatments: critical appraisal of current literature with evidence-based medicine instruments. Surg Endosc 21:697–706CrossRefPubMed Torquati A, Richards WO (2007) Endoluminal GERD treatments: critical appraisal of current literature with evidence-based medicine instruments. Surg Endosc 21:697–706CrossRefPubMed
40.
Zurück zum Zitat Hogan WJ (2006) Clinical trials evaluating endoscopic GERD treatments: is it time for a moratorium on the clinical use of these procedures? Am J Gastroenterol 101:437–439CrossRefPubMed Hogan WJ (2006) Clinical trials evaluating endoscopic GERD treatments: is it time for a moratorium on the clinical use of these procedures? Am J Gastroenterol 101:437–439CrossRefPubMed
41.
Zurück zum Zitat Freston JW, Triadafilopoulos G (2004) Review article: approaches to the long-term management of adults with GERD-proton pump inhibitor therapy, laparoscopic fundoplication or endoscopic therapy? Aliment Pharmacol Ther 19:35–42CrossRefPubMed Freston JW, Triadafilopoulos G (2004) Review article: approaches to the long-term management of adults with GERD-proton pump inhibitor therapy, laparoscopic fundoplication or endoscopic therapy? Aliment Pharmacol Ther 19:35–42CrossRefPubMed
42.
Zurück zum Zitat Gerson LB, Triadafilopoulos G (2001) Proton pump inhibitors and their drug interactions: an evidence-based approach. Eur J Gastroenterol Hepatol 13:611–616CrossRefPubMed Gerson LB, Triadafilopoulos G (2001) Proton pump inhibitors and their drug interactions: an evidence-based approach. Eur J Gastroenterol Hepatol 13:611–616CrossRefPubMed
43.
Zurück zum Zitat Rosen R, Nurko S, Furuta GT (2003) Impeding gastroesophageal refluxate: a new application of an old medication. Gastroenterology 125:984–985CrossRefPubMed Rosen R, Nurko S, Furuta GT (2003) Impeding gastroesophageal refluxate: a new application of an old medication. Gastroenterology 125:984–985CrossRefPubMed
44.
45.
Zurück zum Zitat Strate U, Emmermann A, Fibbe C, Layer P, Zornig C (2008) Laparoscopic fundoplication: Nissen versus Toupet two-year outcome of a prospective randomized study of 200 patients regarding preoperative esophageal motility. Surg Endosc 22:21–30CrossRefPubMed Strate U, Emmermann A, Fibbe C, Layer P, Zornig C (2008) Laparoscopic fundoplication: Nissen versus Toupet two-year outcome of a prospective randomized study of 200 patients regarding preoperative esophageal motility. Surg Endosc 22:21–30CrossRefPubMed
46.
Zurück zum Zitat Guerin E, Betroune K, Closset J, Mehdi A, Lefebvre JC, Houben JJ, Gelin M, Vaneukem P, El Nakadi I (2007) Nissen versus Toupet fundoplication: results of a randomized and multicenter trial. Surg Endosc 21:1985–1990CrossRefPubMed Guerin E, Betroune K, Closset J, Mehdi A, Lefebvre JC, Houben JJ, Gelin M, Vaneukem P, El Nakadi I (2007) Nissen versus Toupet fundoplication: results of a randomized and multicenter trial. Surg Endosc 21:1985–1990CrossRefPubMed
47.
Zurück zum Zitat Biertho L, Sebajang H, Anvari M (2006) Effects of laparoscopic Nissen fundoplication on esophageal motility: long-term results. Surg Endosc 20:619–623CrossRefPubMed Biertho L, Sebajang H, Anvari M (2006) Effects of laparoscopic Nissen fundoplication on esophageal motility: long-term results. Surg Endosc 20:619–623CrossRefPubMed
48.
Zurück zum Zitat Oelschlager BK, Lal DR, Jensen E, Cahill M, Quiroga E, Pellegrini CA (2006) Medium- and long-term outcome of laparoscopic redo fundoplication. Surg Endosc 20:1817–1823CrossRefPubMed Oelschlager BK, Lal DR, Jensen E, Cahill M, Quiroga E, Pellegrini CA (2006) Medium- and long-term outcome of laparoscopic redo fundoplication. Surg Endosc 20:1817–1823CrossRefPubMed
49.
Zurück zum Zitat Youssef YK, Shekar N, Lutfi R, Richards WO, Torquati A (2006) Long-term evaluation of patient satisfaction and reflux symptoms after laparoscopic fundoplication with Collis gastroplasty. Surg Endosc 20:1702–1705CrossRefPubMed Youssef YK, Shekar N, Lutfi R, Richards WO, Torquati A (2006) Long-term evaluation of patient satisfaction and reflux symptoms after laparoscopic fundoplication with Collis gastroplasty. Surg Endosc 20:1702–1705CrossRefPubMed
50.
Zurück zum Zitat Biertho L, Sebajang H, Allen C, Anvari M (2006) Does laparoscopic Nissen fundoplication lead to chronic gastrointestinal dysfunction? Surg Endosc 20:1360–1363CrossRefPubMed Biertho L, Sebajang H, Allen C, Anvari M (2006) Does laparoscopic Nissen fundoplication lead to chronic gastrointestinal dysfunction? Surg Endosc 20:1360–1363CrossRefPubMed
51.
Zurück zum Zitat Zehetner J, Holzinger F, Breuhahn T, Geppert C, Klaiber C (2006) Five-year results of laparoscopic Toupet fundoplication as the primary surgical repair in GERD patients: is it durable? Surg Endosc 20:220–225CrossRefPubMed Zehetner J, Holzinger F, Breuhahn T, Geppert C, Klaiber C (2006) Five-year results of laparoscopic Toupet fundoplication as the primary surgical repair in GERD patients: is it durable? Surg Endosc 20:220–225CrossRefPubMed
52.
Zurück zum Zitat Papasavas PK, Keenan RJ, Yeaney WW, Caushaj PF, Gagne DJ, Landreneau RJ (2003) Effectiveness of laparoscopic fundoplication in relieving the symptoms of gastroesophageal reflux disease (GERD) and eliminating antireflux medical therapy. Surg Endosc 17:1200–1205CrossRefPubMed Papasavas PK, Keenan RJ, Yeaney WW, Caushaj PF, Gagne DJ, Landreneau RJ (2003) Effectiveness of laparoscopic fundoplication in relieving the symptoms of gastroesophageal reflux disease (GERD) and eliminating antireflux medical therapy. Surg Endosc 17:1200–1205CrossRefPubMed
53.
Zurück zum Zitat Contini S, Bertele A, Nervi G, Zinicola R, Scarpignato C (2002) Quality of life for patients with gastroesophageal reflux disease 2 years after laparoscopic fundoplication. Evaluation of the results obtained during the initial experience. Surg Endosc 16:1555–1560CrossRefPubMed Contini S, Bertele A, Nervi G, Zinicola R, Scarpignato C (2002) Quality of life for patients with gastroesophageal reflux disease 2 years after laparoscopic fundoplication. Evaluation of the results obtained during the initial experience. Surg Endosc 16:1555–1560CrossRefPubMed
54.
Zurück zum Zitat Mainie I, Tutuian R, Agrawal A, Adams D, Castell DO (2006) Combined multichannel intraluminal impedance pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg 93:1483–1487CrossRefPubMed Mainie I, Tutuian R, Agrawal A, Adams D, Castell DO (2006) Combined multichannel intraluminal impedance pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg 93:1483–1487CrossRefPubMed
Metadaten
Titel
Evaluating outcomes of endoscopic full-thickness plication for gastroesophageal reflux disease (GERD) with impedance monitoring
verfasst von
Daniel von Renteln
Arthur Schmidt
Bettina Riecken
Karel Caca
Publikationsdatum
01.05.2010
Verlag
Springer-Verlag
Erschienen in
Surgical Endoscopy / Ausgabe 5/2010
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-009-0723-9

Weitere Artikel der Ausgabe 5/2010

Surgical Endoscopy 5/2010 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.